UnitedHealth Group (NYSE:UNH) Given New $360.00 Price Target at SunTrust Banks

UnitedHealth Group (NYSE:UNH) had its price objective upped by stock analysts at SunTrust Banks from $340.00 to $360.00 in a research report issued to clients and investors on Thursday, BenzingaRatingsTable reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. SunTrust Banks’ price objective would indicate a potential upside of 24.16% from the stock’s previous close.

UNH has been the subject of several other reports. Deutsche Bank lowered their price objective on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a report on Thursday, April 16th. Citigroup lowered their target price on UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Credit Suisse Group dropped their price target on UnitedHealth Group from $330.00 to $325.00 and set an “outperform” rating on the stock in a research report on Thursday, April 16th. Stephens increased their price objective on UnitedHealth Group from $300.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Finally, Cowen raised their price objective on UnitedHealth Group from $320.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, April 16th. Four investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $319.68.

UNH traded up $3.03 during trading on Thursday, hitting $289.94. 2,907,540 shares of the stock traded hands, compared to its average volume of 4,276,896. The firm has a market capitalization of $272.10 billion, a P/E ratio of 20.29, a price-to-earnings-growth ratio of 1.41 and a beta of 0.72. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.75 and a quick ratio of 0.75. The firm has a 50-day moving average of $277.58 and a 200 day moving average of $277.14. UnitedHealth Group has a 12-month low of $187.72 and a 12-month high of $306.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.63 by $0.09. The business had revenue of $64.40 billion during the quarter, compared to analysts’ expectations of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.73 EPS. As a group, equities analysts predict that UnitedHealth Group will post 16.24 EPS for the current fiscal year.

In other news, Director Stephen J. Hemsley sold 45,637 shares of the stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the sale, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Richard T. Burke sold 10,000 shares of the stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $228.39, for a total transaction of $2,283,900.00. Following the sale, the director now owns 158,598 shares in the company, valued at approximately $36,222,197.22. The disclosure for this sale can be found here. In the last quarter, insiders have sold 65,637 shares of company stock worth $17,723,013. Corporate insiders own 0.80% of the company’s stock.

Large investors have recently bought and sold shares of the company. Banco Santander S.A. grew its holdings in shares of UnitedHealth Group by 159.4% during the fourth quarter. Banco Santander S.A. now owns 220,432 shares of the healthcare conglomerate’s stock valued at $64,803,000 after buying an additional 135,449 shares during the last quarter. Global Trust Asset Management LLC lifted its position in UnitedHealth Group by 47.9% during the fourth quarter. Global Trust Asset Management LLC now owns 2,160 shares of the healthcare conglomerate’s stock valued at $635,000 after purchasing an additional 700 shares during the period. Dupont Capital Management Corp lifted its position in UnitedHealth Group by 2.4% during the fourth quarter. Dupont Capital Management Corp now owns 87,067 shares of the healthcare conglomerate’s stock valued at $25,596,000 after purchasing an additional 2,004 shares during the period. Essex Financial Services Inc. lifted its position in UnitedHealth Group by 2.0% during the fourth quarter. Essex Financial Services Inc. now owns 10,560 shares of the healthcare conglomerate’s stock valued at $3,105,000 after purchasing an additional 211 shares during the period. Finally, Bluefin Trading LLC lifted its position in UnitedHealth Group by 503.4% during the fourth quarter. Bluefin Trading LLC now owns 36,464 shares of the healthcare conglomerate’s stock valued at $10,720,000 after purchasing an additional 30,421 shares during the period. Hedge funds and other institutional investors own 87.10% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Call Option Volume

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.